NPC 000009: Agency Response Letter
CFSAN/Office of Food Additive Safety
May 19, 2010
Mark S. Krieger, Ph.D.
Dow AgroSciences LLC
9330 Zionsville Road
Indianapolis, IN 46268-1054
Re: NPC 00009; aryloxyalkanoate dioxygenase-12, AAD-12
Dear Dr. Krieger:
This letter is in response to Dow AgroSciences LLC’s (Dow) early food safety evaluation of the protein, aryloxyalkanoate dioxygenase-12, AAD-12, expressed in a new plant variety under development for food use, which you submitted to the Food and Drug Administration (FDA) on December 15, 2008, under FDA’s guidance to industry, “Recommendations for the Early Food Safety Evaluation of New Non-Pesticidal Proteins Produced by New Plant Varieties Intended for Food Use” (71 FR 35688; June 21, 2006, and available on the FDA home page at http://www.fda.gov - follow the hyperlinks from the “Food” topic to the “Biotechnology” program area). As used in the guidance and in this letter, the term “food” refers to both human food and animal feed. All materials relevant to this evaluation have been placed in a file designated NPC 00009. This file will be maintained in the Office of Food Additive Safety in the Center for Food Safety and Applied Nutrition.
In cases of inadvertent low level presence in the food supply of a new food plant variety, FDA believes that any food or feed safety concern would be limited to the safety of the new protein(s) in that plant (generally, the potential allergenicity and toxicity of the new protein(s)). Based on Dow’s early food safety evaluation, it is our understanding that Dow has concluded that AAD-12 protein would not raise food safety concerns when it is in a new food plant variety that is present at low levels in the food supply. We have completed our evaluation of your submission, and we have no questions at this time regarding Dow’s conclusion.
Antonia Mattia, Ph.D.
Division of Biotechnology and GRAS Notice Review
Office of Food Additive Safety
Center for Food Safety and Applied Nutrition